ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Harbour BioMed announces partnership with Kelun-Biotech
biospectrumasia
August 22, 2018The companies will also collaborate in developing combination therapies of A167 with other agents for commercialization in their respective territories. -
Harbour BioMed, Kelun-Biotech Enter Agreement
fiercebiotech
August 22, 2018Harbour BioMed?has entered into an exclusive strategic partnership with?Kelun-Biotech?to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.
Pharma Sources Insight January 2025
